MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
4.810
+0.150 (3.22%)
At close: Jun 26, 2026, 4:00 PM EDT
4.700
-0.110 (-2.29%)
After-hours: Jun 26, 2026, 7:46 PM EDT
MacroGenics Employees
MacroGenics had 293 employees as of December 31, 2025. The number of employees decreased by 48 or -14.08% compared to the previous year.
Employees
293
Change (1Y)
-48
Growth (1Y)
-14.08%
Revenue / Employee
$536,119
Profits / Employee
-$240,130
Market Cap
305.74M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Lyell Immunopharma | 161 |
| Nautilus Biotechnology | 127 |
| Verastem | 102 |
| SAB Biotherapeutics | 86 |
| Lineage Cell Therapeutics | 77 |
| Immuneering | 55 |
| Cybin | 50 |
| Surrozen | 44 |
MGNX News
- 4 days ago - MacroGenics to receive $24.5M milestone payment from Sanofi - TheFly
- 4 days ago - MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval - GlobeNewsWire
- 5 weeks ago - MacroGenics Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
- 6 weeks ago - MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum - GlobeNewsWire
- 6 weeks ago - MacroGenics reports Q1 EPS (58c), consensus (55c) - TheFly
- 6 weeks ago - MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation - GlobeNewsWire
- 6 weeks ago - MacroGenics Quarterly report: Q1 2026 - Filings
- 6 weeks ago - MacroGenics Earnings release: Q1 2026 - Filings